[慢性丙型肝炎病毒基因 1 型感染者的西美瑞韦 (SM)、聚乙二醇化干扰素和利巴韦林 (PR) 三联疗法]。

{"title":"[慢性丙型肝炎病毒基因 1 型感染者的西美瑞韦 (SM)、聚乙二醇化干扰素和利巴韦林 (PR) 三联疗法]。","authors":"Shoko Suzuki, Masayuki Kurosaki, Namiki Izumi","doi":"","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":94159,"journal":{"name":"Nihon rinsho. Japanese journal of clinical medicine","volume":"73 Suppl 9 ","pages":"248-53"},"PeriodicalIF":0.0000,"publicationDate":"2015-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[A triple combination therapy of simeprevir (SM), pegylated-interferon and ribavirin (PR) with chronic hepatitis C virus genotype 1 infection].\",\"authors\":\"Shoko Suzuki, Masayuki Kurosaki, Namiki Izumi\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":94159,\"journal\":{\"name\":\"Nihon rinsho. Japanese journal of clinical medicine\",\"volume\":\"73 Suppl 9 \",\"pages\":\"248-53\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2015-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Nihon rinsho. Japanese journal of clinical medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nihon rinsho. Japanese journal of clinical medicine","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}